Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Mar. 31, 2017	Mar. 31, 2016	Mar. 31, 2015
Cash flows from operating activities
Net loss	$ (24,264)	$ (28,032)	$ (24,647)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	8,170	10,974	2,108
Change in allowance for doubtful accounts	133	(234)	698
Amortization of debt discount and debt issuance costs	1,256	470	34
Accrued interest	36	12	77
Stock-based compensation	3,748	5,095	5,850
Restricted shares and warrants compensation for services rendered	398	867	490
Change in fair value of convertible note embedded derivative liability	(475)	0	0
Change in fair value of warrant liability	(147)	0	0
Loss on extinguishment of debt	293	0	0
Impairment of intangible assets	757	0	0
Stock issued for settlement of liability	0	283	0
(Increase) / decrease in assets:
Restricted cash transferred to / (from) operating cash	(331)	200	0
Accounts receivable	833	(5,111)	(406)
Deposits	92	(104)	(63)
Deferred tax assets	148	(418)	3,156
Prepaid expenses and other current assets	73	57	(142)
Increase / (decrease) in liabilities:
Accounts payable	4,568	7,308	(379)
Accrued license fees and revenue share	(1,093)	2,789	2,988
Accrued compensation	(280)	(831)	325
Other current liabilities	(879)	(394)	(4,589)
Other non-current liabilities	(31)	0	0
Net cash used in operating activities	(6,995)	(7,069)	(14,500)
Cash flows from investing activities
Capital expenditures	(1,595)	(1,549)	(67)
Settlement of contingent liability	0	0	(49)
Cash used in acquisition of assets	0	0	(2,125)
Proceeds from sale of cost method investment in Sift	999	0	0
Net cash proceeds from cost method investment in Sift	0	875	0
Cash acquired with acquisition of subsidiary	0	0	1,363
Net cash used in investing activities	(596)	(674)	(878)
Cash flows from financing activities
Cash received from issuance of convertible notes	16,000	0	0
Repayment of debt obligations	(11,000)	(600)	0
Payment of debt issuance costs	(2,383)	0	0
Options exercised	11	51	136
Warrants exercised	0	0	375
Stock issued for cash in stock offering, net	0	12,627	0
Net cash provided in financing activities	2,628	12,078	511
Effect of exchange rate changes on cash	(119)	(173)	131
Net change in cash	(5,082)	4,162	(14,736)
Cash, beginning of period	11,231	7,069	21,805
Cash, end of period	6,149	11,231	7,069
Interest paid	1,406	1,011	0
Common stock of the Company issued for acquisition of subsidiary	0	0	75,035
Cashless exercise of warrants to purchase common stock of the Company	$ 0	$ 566	$ 0